VS
Vijay Shamrao Patil
About Vijay Shamrao Patil
Data last updated:
Vijay Shamrao Patil is a Director at Lysten Global Pharmaceuticals Private Limited (since 2015). The company operates in Pharma. Lysten Global Pharmaceuticals Private Limited reported revenue of ₹8,000 (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Lysten Global Pharmaceuticals Private Limited U24239PN2015PTC156013 | Director | 04 Nov 2015 | 2015 | ₹8,000 (FY 2023) | Active |
Board colleagues of Vijay Shamrao Patil
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bahubali Kumar Borgave | 07241523 | Lysten Global Pharmaceuticals Private Limited | Director |
| Nitin Parshram Jadhav | 07237608 | Lysten Global Pharmaceuticals Private Limited | Director |
| Sachin Lalasaheb Patil | 07243132 | Lysten Global Pharmaceuticals Private Limited | Director |
| Shilpa Nitin Jadhav | 07347378 | Lysten Global Pharmaceuticals Private Limited | Director |
| Vikas Lalasaheb Patil | 07237588 | Lysten Global Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vijay Shamrao Patil
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vijay Shamrao Patil
Vijay Shamrao Patil currently holds 1 directorship: Lysten Global Pharmaceuticals Private Limited (Director, since 04 Nov 2015, revenue ₹8,000 (FY 2023)).
Vijay Shamrao Patil was first appointed on 04 Nov 2015 as Director at Lysten Global Pharmaceuticals Private Limited.
The current boards of Vijay Shamrao Patil's companies include Bahubali Kumar Borgave (Lysten Global Pharmaceuticals Private Limited), Nitin Parshram Jadhav (Lysten Global Pharmaceuticals Private Limited), Sachin Lalasaheb Patil (Lysten Global Pharmaceuticals Private Limited), Shilpa Nitin Jadhav (Lysten Global Pharmaceuticals Private Limited), Vikas Lalasaheb Patil (Lysten Global Pharmaceuticals Private Limited).